GWAG
AGN

Garrett Wealth Advisory Group’s Allergan plc AGN Stock Holding History

Garrett Wealth Advisory Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-93
Closed -$15.7K – 736
2019
Q3 		$15.7K Buy
+93
New +$15.2K 0.01% 229

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Garrett Wealth Advisory Group's AGN Position: Q4 2019 in Review

Garrett Wealth Advisory Group sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 93 shares — an estimated $15.7K sold.

Garrett Wealth Advisory Group first reported a position in AGN in Q3 2019 and held it in 1 quarter. The position peaked at $15.7K in Q3 2019. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • Garrett Wealth Advisory Group reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
  • Garrett Wealth Advisory Group sold 93 Allergan plc shares in Q4 2019, an estimated $15.7K.
  • Garrett Wealth Advisory Group first reported a position in Allergan plc in Q3 2019 and held it in 1 quarter.
  • Garrett Wealth Advisory Group's Allergan plc position peaked at $15.7K in Q3 2019.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Garrett Wealth Advisory Group's 13F filing for Q4 2019, filed 28 Jan 2020.